Abstract:Apolipoprotein E (APOE) is a risk factor for late-onset Alzheimer's disease (AD). APOE4/4 homozygosity increases AD risk by >10-fold. Although an association between the APOE ε4allele and increased risk has been established, the mechanism by which APOE4 increases disease risk is poorly understood. Here, we hypothesize that APOE4 contributes to disease risk through both cell autonomous and non-cell autonomous mechanisms. We have optimized protocols to develop pure populations of human induced pluripotent stem cells (iPSCs)-derived astrocytes and neurons, determined by immunohistochemistry and global gene expression. For molecular and functional characterization we have established a co-culture system of astrocytes and neurons and measured their activities by the multi-electrode array (MEA), inflammatory and calcium-based assays. APOE4/4 or APOE3/3 iPSCs are being engineered to generate isogenic lines using CRISPR/Cas9 genome-editing. We will then use our differentiation and co-culture strategy to test the impact of APOE genotype in isogenic lines on neuronal and astrocyte gene expression and function. We have developed a protocol to efficiently and reproducibly generate pure populations of astrocytes and neurons from iPSC-derived neuroprogenitor cells (NPCs). Our iPSC-astrocytes are positive for astrocyte markers including S100B, GFAP, GLAST and ALdh1L1. Quantitative PCR confirmed decreased expression of neuronal markers such as TUJ1, MAP2, RELN and CACNA1C. RNAseq comparisons show that iPSC-astrocytes cluster with human fetal astrocytes and not with the source NPCs or matched NPC-derived neurons. Using the MEA platform, we have shown that co-culture of iPSC-excitatory neurons with iPSC-astrocytes is sufficient to improve the neuronal firing of co-cultured iPSC-neurons. iPSC-astrocytes secrete IL-6 in response to treatment with poly I:C, LPS or Ab42 and have constant waves of calcium signals in a manner similar to primary astrocytes. This established co-culture system will be applied to astrocytes and neurons differentiated from APOE4/4 and isogenic APOE3/3iPSC lines. Our optimized differentiation protocol gives consistent results across multiple lines, and significant changes are observed in neuronal activity as a consequence of co-culture of neurons with astrocytes. We are currently co-culturing astrocytes and neurons of different APOE genotypes to determine the impact of APOE4/4 astrocytes on isogenic APOE3/3 neuronal gene expression and activity.

Generation of three isogenic, gene-edited iPSC lines carrying the APOE-Christchurch mutation into the three common APOE variants: APOE2Ch , APOE3Ch and APOE4Ch

The Genetic Risk Effects of APOE Ε4 and Novel Variants on Chinese Familial and Sporadic AD.

APOE3 Christchurch modulates β-catenin/Wnt signaling in iPS cell-derived cerebral organoids from Alzheimer's cases

Inhibitory roles of Apolipoprotein E Christchurch astrocytes in curbing tau propagation using human pluripotent stem cell-derived models

Generation of Inducible Pluripotent Stem Cell Lines from Alzheimer' S Disease Patients with APOE E3/e3 Genotype

Resistance to Autosomal Dominant Alzheimer's Disease in an APOE3 Christchurch Homozygote: a Case Report.

APOE2 mitigates disease-related phenotypes in an isogenic hiPSC-based model of Alzheimer’s disease

EXPLORING CELL AUTONOMOUS AND NON-CELL AUTONOMOUS EFFECTS OF APOE GENOTYPE IN IPSC-DERIVED ASTROCYTES AND NEURONS

APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer’s Disease Phenotypes in Human iPSC-Derived Brain Cell Types

APOE3ch Alleviates Aβ and Tau Pathology and Neurodegeneration in the Human APPNL-G-F Cerebral Organoid Model of Alzheimer’s Disease

APOE3 Christchurch Heterozygosity and Autosomal Dominant Alzheimer's Disease

APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer’s disease patient iPSC-derived cerebral organoids

An integration-free induced pluripotent stem cell line from a 42-year-old female donor with the APOE-ε2/ε2 allele

APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology

Generation of induced pluripotent stem cell line (XWHNi003-A) from a female with APOE gene mutation

The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegeneration and neuroinflammation

P3‐207: APOE4 ACCELERATES NEURODEGENERATION AND EXACERBATES ALZHEIMER'S DISEASE RELATED PATHOLOGY IN CEREBRAL ORGANOIDS

Insertion of the protective APP A673T mutation by CRISPR/Cas9 base editing or PRIME editing

Microglial APOE3 Christchurch protects neurons from Tau pathology in a human iPSC-based model of Alzheimer's disease

β-Amyloid species production and tau phosphorylation in iPSC-neurons with reference to neuropathologically characterized matched donor brains

Generation and characterization of human induced pluripotent stem cell lines from a familial Alzheimer's disease PSEN1 A246E patient and a non-demented family member bearing wild-type PSEN1